Lupin launches Cymbalta generic

BALTIMORE — Lupin Pharmaceuticals on Thursday announced the launch of its duloxetine delayed-release, a generic version of Cymbalta. The drug is available in 20-, 30-, 40- and 60-mg. The company said that its 40-mg strength is among the first generic duloxetine in that strength.

Duloxetine is meant to treat patients with major depressive disorder, generalized anxiety disorder, chronic musculoskeletal pain and diabetic peripheral neuropathic pain.